Steady, it seemed like you were trying to make the case that the peer reviewed path is the one Anavex is pursuing because it is what the FDA expects and I was politely pointing out that not only is it not being pursued but the FDA would have no reason to expect it and it has not been done for other drugs prior to AA early approval decision. Feel free to "spend a few hours with google" to refute this.